
Laurianne Garcia-Ordonez is a Principal at Crédit Mutuel Innovation, a venture capital and growth investment firm. She joined their Life Sciences team in 2018. Her investment areas include Digital Health, Diagnostics, and Impact. **Background and Experience:** * Prior to joining Crédit Mutuel Innovation, Laurianne spent four years at Abbott Diagnostics, where she was responsible for regional and national market share development with Medical Biology Laboratories. * She also worked in the strategic marketing department of CEA on medtech and biotech projects for two years. * Laurianne has experience in neuroscience at GIN, intellectual property at Avenium Consulting, and venture capital at Supernova Invest, where she worked as an analyst. * She has over 10 years of experience in the healthcare market. **Education:** * Laurianne holds a Master's degree in Science from Grenoble Alpes University. * She also holds an International Certificate in Corporate Finance from HEC Paris. * She holds a Master's degree in health and drug engineering from Université Grenoble Alpes. **Role at Crédit Mutuel Innovation:** * Laurianne is a "Directrice de Participations" (Director of Investments). * She represents Crédit Mutuel Innovation. * Since 2018, she has taken responsibility for several companies, including Visible Patient, GenOrph, Inflectis, and Keen Eye. * Laurianne is part of the Health division at Crédit Mutuel Innovation. * Laurianne is located in Nantes.
["Digital Health", "Diagnostics", "Impact", "Life Sciences"]
📍 Based in Paris
Direct Professional Email Pattern
AI Outreach Agent Pitch Writer
Compose an personalized, high-converting outreach message targeting their exact investment interest...